Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Linden Collins

Obstetrics & Gynecology Kansas City, KS Medical Doctor

NPI 1164684890 CMS profile 279308

3901 Rainbow Blvd, Mailstop 2028, Kansas City, KS 66160

Open in the dashboard

General payments

$4,175

207 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$5

5 holdings reported · through program year 2025

Through program year 2025, Linden Collins of Kansas City, KS is reported in the CMS Open Payments database as having received $4,175 across 207 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $5 across 5 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Obstetrics & Gynecology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

12 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $889 35
2024 General $769 35
2023 General $754 39
2022 General $778 39
2021 General $359 19
2020 General $228 15
2019 General $399 25
2024 Ownership $1 1
2023 Ownership $1 1
2022 Ownership $1 1
2021 Ownership $1 1
2020 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Linden Collins
  • Obstetrics & Gynecology median
  • Middle half of Obstetrics & Gynecology
  • National median

In program year 2025, general payments to Linden Collins were reported at $889. Among 21,306 Obstetrics & Gynecology profiles paid that year, the median was $158 and the middle half received between $51 and $401.

Show as a table
Year Linden Collins Obstetrics & Gynecology median Middle half National median
2019 $399 $172 $62–$391 $163
2020 $228 $94 $36–$222 $114
2021 $359 $136 $42–$369 $132
2022 $778 $160 $50–$433 $149
2023 $754 $169 $56–$423 $160
2024 $769 $152 $50–$371 $164
2025 $889 $158 $51–$401 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $688 40 payments
  2. Sumitomo Pharma America, Inc. $525 24 payments
  3. Organon LLC $461 21 payments
  4. Pfizer Inc. $326 16 payments
  5. Astellas Pharma US Inc $297 14 payments
  6. Mayne Pharma Inc. $258 11 payments
  7. Exeltis, USA Inc. $218 13 payments
  8. CooperSurgical, Inc. $134 8 payments
  9. Channel Medsystems, Inc. $134 2 payments
  10. Myovant Sciences Inc. $131 7 payments
  11. Other $1,003 51 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $4,161 206 payments
  2. Education $14 1 payment
Products named General payments · program years 2019–2025
  1. NEXPLANON $424 19 payments
  2. MYFEMBREE Hormone Therapy $411 23 payments
  3. Veozah $297 14 payments
  4. LO LOESTRIN FE $292 19 payments
  5. MYFEMBREE Womens Health $245 8 payments
  6. PREMARIN $228 12 payments
  7. ORILISSA Womens Health $226 13 payments
  8. MYFEMBREE Genitourinary (Sexual Health);Womens Health $195 10 payments
  9. Orilissa Endocrinology $185 10 payments
  10. LILETTA $164 9 payments
  11. Other $2,441 121 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

39

Median for Obstetrics & Gynecology: 65

Drug cost

$2,744

Median for Obstetrics & Gynecology: $3,585

Branded share of claims

0%

Median for Obstetrics & Gynecology: 25.1%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Estradiol Generic 39 $2,744

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 24,311 Part D prescribers listed as Obstetrics & Gynecology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 10 billing codes

Paid by Medicare

$2,065

Medicare's payments for the services billed

Medicare patients

25

Average age 73

Services billed

47

25 women, 0 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 68%
Arthritis 44%
Alzheimer's or dementia 0%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 9 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
Veozah
  • Astellas Pharma US Inc $198
$198 — —
MYFEMBREE
  • Sumitomo Pharma America, Inc. $165
  • PFIZER INC. $21
$185 — —
ABRYSVO
  • PFIZER INC. $31
$31 — —
DUAVEE
  • PFIZER INC. $21
$21 — —
PREMARIN
  • PFIZER INC. $21
$21 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 9 in the dashboard with a free account

Records

207 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Obstetrics & Gynecology in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record